Poly IC and respiratory syncytial virus (RSV) inhibit glucocorticoid receptor (GR)mediated transactivation in lung epithelial but not monocytic cell lines

Virus Research

Volumn 176, Issue 1-2, 2013, Pages 303-306

  Webster Marketon, Jeanette I ^a   Corry, Jacqueline ^a  

^a THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

Author keywords

Epithelial cells; Glucocorticoid receptor; Monocytes; Poly I:C; Respiratory syncytial virus

Indexed keywords

DEXAMETHASONE; GLUCOCORTICOID RECEPTOR; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; POLYINOSINIC POLYCYTIDYLIC ACID;

ARTICLE; GENE ACTIVATION; GENETIC REGULATION; LUNG ALVEOLUS EPITHELIUM; MACROPHAGE; MONOCYTE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; TRANSACTIVATION; CELL CULTURE; CELL LINE; EPITHELIUM CELL; GROWTH, DEVELOPMENT AND AGING; HUMAN; IMMUNOLOGY; INFANT; METABOLISM; TRANSCRIPTION INITIATION; VIROLOGY; HUMAN RESPIRATORY SYNCYTIAL VIRUS;

RESPIRATORY SYNCYTIAL VIRUS; RICE STRIPE VIRUS;

EPITHELIAL CELLS; GLUCOCORTICOID RECEPTOR; MONOCYTES; POLY I:C; RESPIRATORY SYNCYTIAL VIRUS;

CELL LINE; CELLS, CULTURED; EPITHELIAL CELLS; HUMANS; INFANT; MONOCYTES; POLY I-C; RECEPTORS, GLUCOCORTICOID; RESPIRATORY SYNCYTIAL VIRUS, HUMAN; TRANSCRIPTIONAL ACTIVATION;

EID: 84881368948     PISSN: 01681702     EISSN: 18727492     Source Type: Journal    
DOI: 10.1016/j.virusres.2013.06.011     Document Type: Article

References (26)

1. Aeffner F., Traylor Z.P., Yu E.N., Davis I.C. Double-stranded RNA induces similar pulmonary dysfunction to respiratory syncytial virus in BALB/c mice. Am. J. Physiol. Lung Cell. Mol. Physiol. 2011, 301:L99-L109.
2. Bonville C.A., Mehta P.A., Krilov L.R., Rosenberg H.F., Domachowske J.B. Epithelial cells infected with respiratory syncytial virus are resistant to the anti-inflammatory effects of hydrocortisone. Cell. Immunol. 2001, 213:134-140.
3. Buckingham S.C., Jafri H.S., Bush A.J., Carubelli C.M., Sheeran P., Hardy R.D., Ottolini M.G., Ramilo O., DeVincenzo J.P. A randomized, double-blind, placebo-controlled trial of dexamethasone in severe respiratory syncytial virus (RSV) infection: Effects on RSV quantity and clinical outcome. J Infect. Dis. 2002, 185:1222-1228.
4. Bulow S.M., Nir M., Levin E., Friis B., Thomsen L.L., Nielsen J.E., Holm J.C., Moller T., Bonde-Hansen M.E., Nielsen H.E. Prednisolone treatment of respiratory syncytial virus infection: a randomized controlled trial of 147 infants. Pediatrics 1999, 104:e77.
5. Cade A., Brownlee K.G., Conway S.P., Haigh D., Short A., Brown J., Dassu D., Mason S.A., Phillips A., Eglin R., Graham M., Chetcuti A., Chatrath M., Hudson N., Thomas A., Chetcuti P.A. Randomised placebo controlled trial of nebulised corticosteroids in acute respiratory syncytial viral bronchiolitis. Arch. Dis. Child. 2000, 82:126-130.
6. Carpenter L.R., Moy J.N., Roebuck K.A. Respiratory syncytial virus and TNF alpha induction of chemokine gene expression involves differential activation of Rel A and NF-kappa B1. BMC Infect. Dis. 2002, 2:5.
7. Ciencewicki J., Brighton L., Wu W.D., Madden M., Jaspers I. Diesel exhaust enhances virus- and poly(I:C)-induced Toll-like receptor 3 expression and signaling in respiratory epithelial cells. Am. J. Physiol. Lung Cell. Mol. Physiol. 2006, 290:L1154-L1163.
8. de Graaff P.M., de Jong E.C., van Capel T.M., van Dijk M.E., Roholl P.J., Boes J., Luytjes W., Kimpen J.L., van Bleek G.M. Respiratory syncytial virus infection of monocyte-derived dendritic cells decreases their capacity to activate CD4T cells. J. Immunol. 2005, 175:5904-5911.
9. Ermers M.J., Rovers M.M., van Woensel J.B., Kimpen J.L., Bont L.J. The effect of high dose inhaled corticosteroids on wheeze in infants after respiratory syncytial virus infection: Randomised double blind placebo controlled trial. BMJ 2009, 338:b897.
10. Falsey A.R., Walsh E.E. Respiratory syncytial virus infection in elderly adults. Drugs Aging 2005, 22:577-587.
11. Ge X., Rameix-Welti M.A., Gault E., Chase G., dos Santos Afonso E., Picard D., Schwemmle M., Naffakh N. Influenza virus infection induces the nuclear relocalization of the Hsp90 co-chaperone p23 and inhibits the glucocorticoid receptor response. PLoS One 2011, 6:e23368.
12. Guillot L., Le Goffic R., Bloch S., Escriou N., Akira S., Chignard M., Si-Tahar M. Involvement of toll-like receptor 3 in the immune response of lung epithelial cells to double-stranded RNA and influenza A virus. J. Biol. Chem. 2005, 280:5571-5580.
13. Hallak L.K., Spillmann D., Collins P.L., Peeples M.E. Glycosaminoglycan sulfation requirements for respiratory syncytial virus infection. J. Virol. 2000, 74:10508-10513.
14. Hinzey A., Alexander J., Corry J., Adams K.M., Claggett A.M., Traylor Z.P., Davis I.C., Webster Marketon J.I. Respiratory syncytial virus represses glucocorticoid receptor-mediated gene activation. Endocrinology 2011, 152:483-494.
15. Jaovisidha P., Peeples M.E., Brees A.A., Carpenter L.R., Moy J.N. Respiratory syncytial virus stimulates neutrophil degranulation and chemokine release. J. Immunol. 1999, 163(5):2816-2820.
16. Loppow D., Schleiss M.B., Kanniess F., Taube C., Jorres R.A., Magnussen H. In patients with chronic bronchitis a four week trial with inhaled steroids does not attenuate airway inflammation. Respir. Med. 2001, 95:115-121.
17. Midulla F., Huang Y.T., Gilbert I.A., Cirino N.M., McFadden E.R., Panuska J.R. Respiratory syncytial virus infection of human cord and adult blood monocytes and alveolar macrophages. Am. Rev. Respir. Dis. 1989, 140:771-777.
18. Panickar J., Lakhanpaul M., Lambert P.C., Kenia P., Stephenson T., Smyth A., Grigg J. Oral prednisolone for preschool children with acute virus-induced wheezing. N. Engl. J. Med. 2009, 360:329-338.
19. Paramore L.C., Ciuryla V., Ciesla G., Liu L. Economic impact of respiratory syncytial virus-related illness in the US: an analysis of national databases. Pharmacoeconomics 2004, 22:275-284.
20. Raboni S.M., Nogueira M.B., Tsuchiya L.R., Takahashi G.A., Pereira L.A., Pasquini R., Siqueira M.M. Respiratory tract viral infections in bone marrow transplant patients. Transplantation 2003, 76:142-146.
21. Richter H., Seddon P. Early nebulized budesonide in the treatment of bronchiolitis and the prevention of postbronchiolitic wheezing. J. Pediatr. 1998, 132:849-853.
22. Ritter M., Mennerich D., Weith A., Seither P. Characterization of Toll-like receptors in primary lung epithelial cells: strong impact of the TLR3 ligand poly(I:C) on the regulation of Toll-like receptors, adaptor proteins and inflammatory response. J. Inflamm. 2005, 2:16.
23. Roosevelt G., Sheehan K., Grupp-Phelan J., Tanz R.R., Listernick R. Dexamethasone in bronchiolitis. A randomised controlled trial. Lancet 1996, 348:292-295.
24. Somers C.C., Ahmad N., Mejias A., Buckingham S.C., Carubelli C., Katz K., Leos N., Gomez A.M., DeVincenzo J.P., Ramilo O., Jafri H.S. Effect of dexamethasone on respiratory syncytial virus-induced lung inflammation in children: Results of a randomized, placebo controlled clinical trial. Pediatr. Allergy Immunol. 2009, 20:477-485.
25. Stockman L.J., Curns A.T., Anderson L.J., Fischer-Langley G. Respiratory syncytial virus-associated hospitalizations among infants and young children in the United States, 1997-2006. Pediatr. Infect. Dis. J. 2012, 31:5-9.
26. Wang J.C., Derynck M.K., Nonaka D.F., Khodabakhsh D.B., Haqq C., Yamamoto K.R. Chromatin immunoprecipitation (ChIP) scanning identifies primary glucocorticoid receptor target genes. Proc. Natl. Acad. Sci. USA 2004, 101:15603-15608.